SCOTT WILLOUGHBY: Open Payments
NPI 1457897852 · MERIDIAN, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,217 in 54 payments from 25 companies in 2025. Trend: 2023 $1,334 · 2024 $1,434 · 2025 $1,217
Food & beverage: $1,217
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 9 | $184 |
| Novo Nordisk Inc | 6 | $120 |
| Teva Pharmaceuticals USA, Inc. | 4 | $109 |
| Exact Sciences Corporation | 3 | $88 |
| Otsuka America Pharmaceutical, Inc. | 4 | $88 |
| ABBVIE INC. | 3 | $76 |
| Stryker Corporation | 2 | $66 |
| PFIZER INC. | 3 | $65 |
| Aimmune Therapeutics, Inc. | 2 | $48 |
| AstraZeneca Pharmaceuticals LP | 2 | $44 |
Products named: INGREZZA, AUSTEDO XR, Cologuard Collection Kit, REXULTI, MAKO, NURTEC ODT, Wegovy, ZENPEP.
Industry payments across ID — which companies pay providers there.
